Paget Disease Treatment Market is expected to reach US$ 2.45 Bn. at a CAGR of 3.27% during the forecast period 2029. Paget disease of bone, which is also known as Osteitis deformans is a common disorder, which affects a single bone (monostotic) or multiple bones (poly-ostotic) resulting in abnormally long, weak and brittle bone structure. Most commonly involved bones include the pelvis, femur, spine, skull and tibia. Although many patients are asymptomatic, a variety of symptoms and complications may occur. It is frequently discovered when serum alkaline phosphatase (SAP) is found elevated in routine laboratory testing.Paget Disease Treatment Market Snapshot
To know about the Research Methodology:- Request Free Sample Report It is the second highest bone remodeling disease after osteoporosis and mainly occurs in 3% white adults older than 55 years of age. Prevalence of this disease is most common in United Kingdom and Northern Europe as compared to any other race. It is rarely reported in Asia and Africa.
Global Paget Disease Treatment Market Dynamics:
The ongoing Research & Development along with the growing biotechnology research expenditure in the field is helping to boost the market. Owing to the increasing awareness regarding the disease among people, global Paget’s disease treatment market grew by xx% from 2018 to 2022 and is expected to grow by xx% in the forecast period. Complications such as arthritis and fractures arising due to absence of treatment are driving the market. Also, the geriatric population who are highly susceptible to this disease are fueling the market.Global Paget Disease Treatment Market Regional insights
North America dominates the Global Paget Disease Treatment Market. North America held highest market share in the global market owing to awareness about the rare orthopedic diseases and treatment. Also the rising geriatric population is one of the key drivers in North America. Number of patients in Europe are expected to increase in forecast period and in APAC market, India, China & Japan are expected to follow the European market.Global Paget Disease Treatment Market segmentation
Global Paget Disease Treatment Market, By drug-class
Bisphosphonates Calcitonin analogues Calcium supplements Vitamin-D supplements Analgesics Demand for Bisphosphonates is higher for the treatment of Paget Disease. Bisphosphonates are used as first line treatment against this disease. Bisphosphonates slowdown the bone remodeling process to restrain disease progression and avoid complications. Owing to this key feature it is anticipated to dominate throughout the forecast period. Along with this, researchers have also predicted that the supplements of vitamin d & calcium and analgesics will also gain momentum in this market in the forecast period. Oral supplements of calcium and Vitamin D are recommended for patients as therapy to lower the rate of hypocalcaemia. Etidronate (Didronel), tiludronate (Skelid), alendronate (Fosamax), and risedronate (Actonel) are taken orally. The objective of the report is to present a comprehensive analysis of the Global Paget Disease Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Paget Disease Treatment Market dynamics, structure by analyzing the market segments and project the Global Paget Disease Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Paget Disease Treatment Market make the report investor’s guide.Global Paget Disease Treatment Market Competitive Landscape:
In 2017, Mylan NV launched Zoledronic acid injection in the U.S., which is a generic version of Novartis AG’s Reclast injection. The U.S. Food and Drug Administration gave the final approval for the product application indicated for the treatment of the Paget Disease of bone in men and women.Scope of Global Paget Disease Treatment Market: Inquire before buying
Global Paget Disease Treatment Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 1.95 Bn. Forecast Period 2023 to 2029 CAGR: 3.27% Market Size in 2029: US $ 2.45 Bn. Segments Covered: by Distribution Channels Hospital pharmacies Retail pharmacies Drug stores by Route of Administration Oral Intravenous Topical Global Paget Disease Treatment Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Global Paget Disease Treatment Market, Key Players are
1.Novartis AG 2. Teva Pharmaceutical Industries Ltd. 3. Mylan NV 4. Neopharma Inc. 5. Allergan 6. Sanofi S.A. 7. Fresenius Kabi 8. Mallinckrodt Pharmaceuticals 9. Sun Pharmaceutical Industries Ltd. Frequently Asked Questions: 1. Which region has the largest share in Global Paget Disease Treatment Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Market? Ans: The Global Market is growing at a CAGR of 3.27% during forecasting period 2023-2029. 3. What is scope of the Global Market report? Ans: Global PMarket report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Market? Ans: The important key players in the Global Market are – Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan NV, Neopharma Inc., Allergan, Sanofi S.A., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd. 5. What is the study period of this Market? Ans: The Global Market is studied from 2022 to 2029.
Global Paget Disease Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Paget Disease Treatment Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Paget Disease Treatment Market Analysis and Forecast 6.1. Paget Disease Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Paget Disease Treatment Market Analysis and Forecast, By Drug-Class 7.1. Introduction and Definition 7.2. Key Findings 7.3. Paget Disease Treatment Market Value Share Analysis, By Drug-Class 7.4. Paget Disease Treatment Market Size (US$ Mn) Forecast, By Drug-Class 7.5. Paget Disease Treatment Market Analysis, By Drug-Class 7.6. Paget Disease Treatment Market Attractiveness Analysis, By Drug-Class 8. Global Paget Disease Treatment Market Analysis and Forecast, By Distribution Channels 8.1. Introduction and Definition 8.2. Key Findings 8.3. Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 8.4. Paget Disease Treatment Market Size (US$ Mn) Forecast, By Distribution Channels 8.5. Paget Disease Treatment Market Analysis, By Distribution Channels 8.6. Paget Disease Treatment Market Attractiveness Analysis, By Distribution Channels 9. Global Paget Disease Treatment Market Analysis and Forecast, By Route Of Administration 9.1. Introduction and Definition 9.2. Key Findings 9.3. Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 9.4. Paget Disease Treatment Market Size (US$ Mn) Forecast, By Route Of Administration 9.5. Paget Disease Treatment Market Analysis, By Route Of Administration 9.6. Paget Disease Treatment Market Attractiveness Analysis, By Route Of Administration 10. Global Paget Disease Treatment Market Analysis, by Region 10.1. Paget Disease Treatment Market Value Share Analysis, by Region 10.2. Paget Disease Treatment Market Size (US$ Mn) Forecast, by Region 10.3. Paget Disease Treatment Market Attractiveness Analysis, by Region 11. North America Paget Disease Treatment Market Analysis 11.1. Key Findings 11.2. North America Paget Disease Treatment Market Overview 11.3. North America Paget Disease Treatment Market Value Share Analysis, By Drug-Class 11.4. North America Paget Disease Treatment Market Forecast, By Drug-Class 11.4.1. Bisphosphonates 11.4.2. Calcitonin analogues 11.4.3. Calcium supplements 11.4.4. Vitamin-D supplements 11.4.5. Analgesics 11.5. North America Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 11.6. North America Paget Disease Treatment Market Forecast, By Distribution Channels 11.6.1. Hospital pharmacies 11.6.2. Retail pharmacies 11.6.3. Drug stores 11.7. North America Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 11.8. North America Paget Disease Treatment Market Forecast, By Route Of Administration 11.8.1. Oral 11.8.2. Intravenous 11.8.3. Topical 11.9. North America Paget Disease Treatment Market Value Share Analysis, by Country 11.10. North America Paget Disease Treatment Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.10.3. Mexico 11.11. North America Paget Disease Treatment Market Analysis, by Country 11.12. U.S. Paget Disease Treatment Market Forecast, By Drug-Class 11.12.1. Bisphosphonates 11.12.2. Calcitonin analogues 11.12.3. Calcium supplements 11.12.4. Vitamin-D supplements 11.12.5. Analgesics 11.13. U.S. Paget Disease Treatment Market Forecast, By Distribution Channels 11.13.1. Hospital pharmacies 11.13.2. Retail pharmacies 11.13.3. Drug stores 11.14. U.S. Paget Disease Treatment Market Forecast, By Route Of Administration 11.14.1. Oral 11.14.2. Intravenous 11.14.3. Topical 11.15. Canada Paget Disease Treatment Market Forecast, By Drug-Class 11.15.1. Bisphosphonates 11.15.2. Calcitonin analogues 11.15.3. Calcium supplements 11.15.4. Vitamin-D supplements 11.15.5. Analgesics 11.16. Canada Paget Disease Treatment Market Forecast, By Distribution Channels 11.16.1. Hospital pharmacies 11.16.2. Retail pharmacies 11.16.3. Drug stores 11.17. Canada Paget Disease Treatment Market Forecast, By Route Of Administration 11.17.1. Oral 11.17.2. Intravenous 11.17.3. Topical 11.18. Mexico Paget Disease Treatment Market Forecast, By Drug-Class 11.18.1. Bisphosphonates 11.18.2. Calcitonin analogues 11.18.3. Calcium supplements 11.18.4. Vitamin-D supplements 11.18.5. Analgesics 11.19. Mexico Paget Disease Treatment Market Forecast, By Distribution Channels 11.19.1. Hospital pharmacies 11.19.2. Retail pharmacies 11.19.3. Drug stores 11.20. Mexico Paget Disease Treatment Market Forecast, By Route Of Administration 11.20.1. Oral 11.20.2. Intravenous 11.20.3. Topical 11.21. North America Paget Disease Treatment Market Attractiveness Analysis 11.21.1. By Drug-Class 11.21.2. By Distribution Channels 11.21.3. By Route Of Administration 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Paget Disease Treatment Market Analysis 12.1. Key Findings 12.2. Europe Paget Disease Treatment Market Overview 12.3. Europe Paget Disease Treatment Market Value Share Analysis, By Drug-Class 12.4. Europe Paget Disease Treatment Market Forecast, By Drug-Class 12.4.1. Bisphosphonates 12.4.2. Calcitonin analogues 12.4.3. Calcium supplements 12.4.4. Vitamin-D supplements 12.4.5. Analgesics 12.5. Europe Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 12.6. Europe Paget Disease Treatment Market Forecast, By Distribution Channels 12.6.1. Hospital pharmacies 12.6.2. Retail pharmacies 12.6.3. Drug stores 12.7. Europe Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 12.8. Europe Paget Disease Treatment Market Forecast, By Route Of Administration 12.8.1. Oral 12.8.2. Intravenous 12.8.3. Topical 12.9. Europe Paget Disease Treatment Market Value Share Analysis, by Country 12.10. Europe Paget Disease Treatment Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Sweden 12.10.7. CIS countries 12.10.8. Rest of Europe 12.11. Europe Paget Disease Treatment Market Analysis, by Country 12.12. Germany Paget Disease Treatment Market Forecast, By Drug-Class 12.12.1. Bisphosphonates 12.12.2. Calcitonin analogues 12.12.3. Calcium supplements 12.12.4. Vitamin-D supplements 12.12.5. Analgesics 12.13. Germany Paget Disease Treatment Market Forecast, By Distribution Channels 12.13.1. Hospital pharmacies 12.13.2. Retail pharmacies 12.13.3. Drug stores 12.14. Germany Paget Disease Treatment Market Forecast, By Route Of Administration 12.14.1. Oral 12.14.2. Intravenous 12.14.3. Topical 12.15. U.K. Paget Disease Treatment Market Forecast, By Drug-Class 12.15.1. Bisphosphonates 12.15.2. Calcitonin analogues 12.15.3. Calcium supplements 12.15.4. Vitamin-D supplements 12.15.5. Analgesics 12.16. U.K. Paget Disease Treatment Market Forecast, By Distribution Channels 12.16.1. Hospital pharmacies 12.16.2. Retail pharmacies 12.16.3. Drug stores 12.17. U.K. Paget Disease Treatment Market Forecast, By Route Of Administration 12.17.1. Oral 12.17.2. Intravenous 12.17.3. Topical 12.18. France Paget Disease Treatment Market Forecast, By Drug-Class 12.18.1. Bisphosphonates 12.18.2. Calcitonin analogues 12.18.3. Calcium supplements 12.18.4. Vitamin-D supplements 12.18.5. Analgesics 12.19. France Paget Disease Treatment Market Forecast, By Distribution Channels 12.19.1. Hospital pharmacies 12.19.2. Retail pharmacies 12.19.3. Drug stores 12.20. France Paget Disease Treatment Market Forecast, By Route Of Administration 12.20.1. Oral 12.20.2. Intravenous 12.20.3. Topical 12.21. Italy Paget Disease Treatment Market Forecast, By Drug-Class 12.21.1. Bisphosphonates 12.21.2. Calcitonin analogues 12.21.3. Calcium supplements 12.21.4. Vitamin-D supplements 12.21.5. Analgesics 12.22. Italy Paget Disease Treatment Market Forecast, By Distribution Channels 12.22.1. Hospital pharmacies 12.22.2. Retail pharmacies 12.22.3. Drug stores 12.23. Italy Paget Disease Treatment Market Forecast, By Route Of Administration 12.23.1. Oral 12.23.2. Intravenous 12.23.3. Topical 12.24. Spain Paget Disease Treatment Market Forecast, By Drug-Class 12.24.1. Bisphosphonates 12.24.2. Calcitonin analogues 12.24.3. Calcium supplements 12.24.4. Vitamin-D supplements 12.24.5. Analgesics 12.25. Spain Paget Disease Treatment Market Forecast, By Distribution Channels 12.25.1. Hospital pharmacies 12.25.2. Retail pharmacies 12.25.3. Drug stores 12.26. Spain Paget Disease Treatment Market Forecast, By Route Of Administration 12.26.1. Oral 12.26.2. Intravenous 12.26.3. Topical 12.27. Sweden Paget Disease Treatment Market Forecast, By Drug-Class 12.27.1. Bisphosphonates 12.27.2. Calcitonin analogues 12.27.3. Calcium supplements 12.27.4. Vitamin-D supplements 12.27.5. Analgesics 12.28. Sweden Paget Disease Treatment Market Forecast, By Distribution Channels 12.28.1. Hospital pharmacies 12.28.2. Retail pharmacies 12.28.3. Drug stores 12.29. Sweden Paget Disease Treatment Market Forecast, By Route Of Administration 12.29.1. Oral 12.29.2. Intravenous 12.29.3. Topical 12.30. CIS countries Paget Disease Treatment Market Forecast, By Drug-Class 12.30.1. Bisphosphonates 12.30.2. Calcitonin analogues 12.30.3. Calcium supplements 12.30.4. Vitamin-D supplements 12.30.5. Analgesics 12.31. CIS countries Paget Disease Treatment Market Forecast, By Distribution Channels 12.31.1. Hospital pharmacies 12.31.2. Retail pharmacies 12.31.3. Drug stores 12.32. CIS countries Paget Disease Treatment Market Forecast, By Route Of Administration 12.32.1. Oral 12.32.2. Intravenous 12.32.3. Topical 12.33. Rest of Europe Paget Disease Treatment Market Forecast, By Drug-Class 12.33.1. Bisphosphonates 12.33.2. Calcitonin analogues 12.33.3. Calcium supplements 12.33.4. Vitamin-D supplements 12.33.5. Analgesics 12.34. Rest of Europe Paget Disease Treatment Market Forecast, By Distribution Channels 12.34.1. Hospital pharmacies 12.34.2. Retail pharmacies 12.34.3. Drug stores 12.35. Rest of Europe Paget Disease Treatment Market Forecast, By Route Of Administration 12.35.1. Oral 12.35.2. Intravenous 12.35.3. Topical 12.36. Europe Paget Disease Treatment Market Attractiveness Analysis 12.36.1. By Drug-Class 12.36.2. By Distribution Channels 12.36.3. By Route Of Administration 12.37. PEST Analysis 12.38. Key Trends 12.39. Key Developments 13. Asia Pacific Paget Disease Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Paget Disease Treatment Market Overview 13.3. Asia Pacific Paget Disease Treatment Market Value Share Analysis, By Drug-Class 13.4. Asia Pacific Paget Disease Treatment Market Forecast, By Drug-Class 13.4.1. Bisphosphonates 13.4.2. Calcitonin analogues 13.4.3. Calcium supplements 13.4.4. Vitamin-D supplements 13.4.5. Analgesics 13.5. Asia Pacific Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 13.6. Asia Pacific Paget Disease Treatment Market Forecast, By Distribution Channels 13.6.1. Hospital pharmacies 13.6.2. Retail pharmacies 13.6.3. Drug stores 13.7. Asia Pacific Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 13.8. Asia Pacific Paget Disease Treatment Market Forecast, By Route Of Administration 13.8.1. Oral 13.8.2. Intravenous 13.8.3. Topical 13.9. Asia Pacific Paget Disease Treatment Market Value Share Analysis, by Country 13.10. Asia Pacific Paget Disease Treatment Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. South Korea 13.10.5. Australia 13.10.6. ASEAN 13.10.7. Rest of Asia Pacific 13.11. Asia Pacific Paget Disease Treatment Market Analysis, by Country 13.12. China Paget Disease Treatment Market Forecast, By Drug-Class 13.12.1. Bisphosphonates 13.12.2. Calcitonin analogues 13.12.3. Calcium supplements 13.12.4. Vitamin-D supplements 13.12.5. Analgesics 13.13. China Paget Disease Treatment Market Forecast, By Distribution Channels 13.13.1. Hospital pharmacies 13.13.2. Retail pharmacies 13.13.3. Drug stores 13.14. China Paget Disease Treatment Market Forecast, By Route Of Administration 13.14.1. Oral 13.14.2. Intravenous 13.14.3. Topical 13.15. India Paget Disease Treatment Market Forecast, By Drug-Class 13.15.1. Bisphosphonates 13.15.2. Calcitonin analogues 13.15.3. Calcium supplements 13.15.4. Vitamin-D supplements 13.15.5. Analgesics 13.16. India Paget Disease Treatment Market Forecast, By Distribution Channels 13.16.1. Hospital pharmacies 13.16.2. Retail pharmacies 13.16.3. Drug stores 13.17. India Paget Disease Treatment Market Forecast, By Route Of Administration 13.17.1. Oral 13.17.2. Intravenous 13.17.3. Topical 13.18. Japan Paget Disease Treatment Market Forecast, By Drug-Class 13.18.1. Bisphosphonates 13.18.2. Calcitonin analogues 13.18.3. Calcium supplements 13.18.4. Vitamin-D supplements 13.18.5. Analgesics 13.19. Japan Paget Disease Treatment Market Forecast, By Distribution Channels 13.19.1. Hospital pharmacies 13.19.2. Retail pharmacies 13.19.3. Drug stores 13.20. Japan Paget Disease Treatment Market Forecast, By Route Of Administration 13.20.1. Oral 13.20.2. Intravenous 13.20.3. Topical 13.21. South Korea Paget Disease Treatment Market Forecast, By Drug-Class 13.21.1. Bisphosphonates 13.21.2. Calcitonin analogues 13.21.3. Calcium supplements 13.21.4. Vitamin-D supplements 13.21.5. Analgesics 13.22. South Korea Paget Disease Treatment Market Forecast, By Distribution Channels 13.22.1. Hospital pharmacies 13.22.2. Retail pharmacies 13.22.3. Drug stores 13.23. South Korea Paget Disease Treatment Market Forecast, By Route Of Administration 13.23.1. Oral 13.23.2. Intravenous 13.23.3. Topical 13.24. Australia Paget Disease Treatment Market Forecast, By Drug-Class 13.24.1. Bisphosphonates 13.24.2. Calcitonin analogues 13.24.3. Calcium supplements 13.24.4. Vitamin-D supplements 13.24.5. Analgesics 13.25. Australia Paget Disease Treatment Market Forecast, By Distribution Channels 13.25.1. Hospital pharmacies 13.25.2. Retail pharmacies 13.25.3. Drug stores 13.26. Australia Paget Disease Treatment Market Forecast, By Route Of Administration 13.26.1. Oral 13.26.2. Intravenous 13.26.3. Topical 13.27. ASEAN Paget Disease Treatment Market Forecast, By Distribution Channels 13.27.1. Hospital pharmacies 13.27.2. Retail pharmacies 13.27.3. Drug stores 13.28. ASEAN Paget Disease Treatment Market Forecast, By Route Of Administration 13.28.1. Oral 13.28.2. Intravenous 13.28.3. Topical 13.29. Rest of Asia Pacific Paget Disease Treatment Market Forecast, By Drug-Class 13.29.1. Bisphosphonates 13.29.2. Calcitonin analogues 13.29.3. Calcium supplements 13.29.4. Vitamin-D supplements 13.29.5. Analgesics 13.30. Rest of Asia Pacific Paget Disease Treatment Market Forecast, By Distribution Channels 13.30.1. Hospital pharmacies 13.30.2. Retail pharmacies 13.30.3. Drug stores 13.31. Rest of Asia Pacific Paget Disease Treatment Market Forecast, By Route Of Administration 13.31.1. Oral 13.31.2. Intravenous 13.31.3. Topical 13.32. Asia Pacific Paget Disease Treatment Market Attractiveness Analysis 13.32.1. By Drug-Class 13.32.2. By Distribution Channels 13.32.3. By Route Of Administration 13.33. PEST Analysis 13.34. Key Trends 13.35. Key Developments 14. Middle East & Africa Paget Disease Treatment Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Paget Disease Treatment Market Overview 14.3. Middle East & Africa Paget Disease Treatment Market Value Share Analysis, By Drug-Class 14.4. Middle East & Africa Paget Disease Treatment Market Forecast, By Drug-Class 14.4.1. Bisphosphonates 14.4.2. Calcitonin analogues 14.4.3. Calcium supplements 14.4.4. Vitamin-D supplements 14.4.5. Analgesics 14.5. Middle East & Africa Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 14.6. Middle East & Africa Paget Disease Treatment Market Forecast, By Distribution Channels 14.6.1. Hospital pharmacies 14.6.2. Retail pharmacies 14.6.3. Drug stores 14.7. Middle East & Africa Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 14.8. Middle East & Africa Paget Disease Treatment Market Forecast, By Route Of Administration 14.8.1. Oral 14.8.2. Intravenous 14.8.3. Topical 14.9. Middle East & Africa Paget Disease Treatment Market Value Share Analysis, by Country 14.10. Middle East & Africa Paget Disease Treatment Market Forecast, by Country 14.10.1. GCC Countries 14.10.2. South Africa 14.10.3. Nigeria 14.10.4. Egypt 14.10.5. Rest of Middle East & Africa 14.11. Middle East & Africa Paget Disease Treatment Market Analysis, by Country 14.12. GCC COUNTRIES Paget Disease Treatment Market Forecast, By Drug-Class 14.12.1. Bisphosphonates 14.12.2. Calcitonin analogues 14.12.3. Calcium supplements 14.12.4. Vitamin-D supplements 14.12.5. Analgesics 14.13. GCC COUNTRIES Paget Disease Treatment Market Forecast, By Distribution Channels 14.13.1. Hospital pharmacies 14.13.2. Retail pharmacies 14.13.3. Drug stores 14.14. GCC COUNTRIES Paget Disease Treatment Market Forecast, By Route Of Administration 14.14.1. Oral 14.14.2. Intravenous 14.14.3. Topical 14.15. South Africa Paget Disease Treatment Market Forecast, By Drug-Class 14.15.1. Bisphosphonates 14.15.2. Calcitonin analogues 14.15.3. Calcium supplements 14.15.4. Vitamin-D supplements 14.15.5. Analgesics 14.16. South Africa Paget Disease Treatment Market Forecast, By Distribution Channels 14.16.1. Hospital pharmacies 14.16.2. Retail pharmacies 14.16.3. Drug stores 14.17. South Africa Paget Disease Treatment Market Forecast, By Route Of Administration 14.17.1. Oral 14.17.2. Intravenous 14.17.3. Topical 14.18. Nigeria Paget Disease Treatment Market Forecast, By Drug-Class 14.18.1. Bisphosphonates 14.18.2. Calcitonin analogues 14.18.3. Calcium supplements 14.18.4. Vitamin-D supplements 14.18.5. Analgesics 14.19. Nigeria Paget Disease Treatment Market Forecast, By Distribution Channels 14.19.1. Hospital pharmacies 14.19.2. Retail pharmacies 14.19.3. Drug stores 14.20. Nigeria Paget Disease Treatment Market Forecast, By Route Of Administration 14.20.1. Oral 14.20.2. Intravenous 14.20.3. Topical 14.21. Egypt Nigeria Paget Disease Treatment Market Forecast, By Drug-Class 14.21.1. Bisphosphonates 14.21.2. Calcitonin analogues 14.21.3. Calcium supplements 14.21.4. Vitamin-D supplements 14.21.5. Analgesics 14.22. Egypt Nigeria Paget Disease Treatment Market Forecast, By Distribution Channels 14.22.1. Hospital pharmacies 14.22.2. Retail pharmacies 14.22.3. Drug stores 14.23. Egypt Paget Disease Treatment Market Forecast, By Route Of Administration 14.23.1. Oral 14.23.2. Intravenous 14.23.3. Topical 14.24. Rest of Middle East & Africa Paget Disease Treatment Market Forecast, By Drug-Class 14.24.1. Bisphosphonates 14.24.2. Calcitonin analogues 14.24.3. Calcium supplements 14.24.4. Vitamin-D supplements 14.24.5. Analgesics 14.25. Rest of Middle East & Africa Paget Disease Treatment Market Forecast, By Distribution Channels 14.25.1. Hospital pharmacies 14.25.2. Retail pharmacies 14.25.3. Drug stores 14.26. Rest of Middle East & Africa Paget Disease Treatment Market Forecast, By Route Of Administration 14.26.1. Oral 14.26.2. Intravenous 14.26.3. Topical 14.27. Middle East & Africa Paget Disease Treatment Market Attractiveness Analysis 14.27.1. By Distribution Channels 14.27.2. By Drug-Class 14.27.3. By Route Of Administration 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Paget Disease Treatment Market Analysis 15.1. Key Findings 15.2. South America Paget Disease Treatment Market Overview 15.3. South America Paget Disease Treatment Market Value Share Analysis, By Drug-Class 15.4. South America Paget Disease Treatment Market Forecast, By Drug-Class 15.4.1. Bisphosphonates 15.4.2. Calcitonin analogues 15.4.3. Calcium supplements 15.4.4. Vitamin-D supplements 15.4.5. Analgesics 15.5. South America Paget Disease Treatment Market Value Share Analysis, By Distribution Channels 15.6. South America Paget Disease Treatment Market Forecast, By Distribution Channels 15.6.1. Hospital pharmacies 15.6.2. Retail pharmacies 15.6.3. Drug stores 15.7. South America Paget Disease Treatment Market Value Share Analysis, By Route Of Administration 15.8. South America Paget Disease Treatment Market Forecast, By Route Of Administration 15.8.1. Oral 15.8.2. Intravenous 15.8.3. Topical 15.9. South America Paget Disease Treatment Market Value Share Analysis, by Country 15.10. South America Paget Disease Treatment Market Forecast, by Country 15.10.1. Brazil 15.10.2. Argentina 15.10.3. Colombia 15.10.4. Rest of South America 15.11. South America Paget Disease Treatment Market Analysis, By Drug-Class 15.12. Brazil Paget Disease Treatment Market Forecast, By Drug-Class 15.12.1. Bisphosphonates 15.12.2. Calcitonin analogues 15.12.3. Calcium supplements 15.12.4. Vitamin-D supplements 15.12.5. Analgesics 15.13. Brazil Paget Disease Treatment Market Forecast, By Distribution Channels 15.13.1. Hospital pharmacies 15.13.2. Retail pharmacies 15.13.3. Drug stores 15.14. Brazil Paget Disease Treatment Market Forecast, By Route Of Administration 15.14.1. Oral 15.14.2. Intravenous 15.14.3. Topical 15.15. Argentina Paget Disease Treatment Market Forecast, By Drug-Class 15.15.1. Bisphosphonates 15.15.2. Calcitonin analogues 15.15.3. Calcium supplements 15.15.4. Vitamin-D supplements 15.15.5. Analgesics 15.16. Argentina Paget Disease Treatment Market Forecast, By Distribution Channels 15.16.1. Hospital pharmacies 15.16.2. Retail pharmacies 15.16.3. Drug stores 15.17. Argentina Paget Disease Treatment Market Forecast, By Route Of Administration 15.17.1. Oral 15.17.2. Intravenous 15.17.3. Topical 15.18. Colombia Paget Disease Treatment Market Forecast, By Drug-Class 15.18.1. Bisphosphonates 15.18.2. Calcitonin analogues 15.18.3. Calcium supplements 15.18.4. Vitamin-D supplements 15.18.5. Analgesics 15.19. Colombia Paget Disease Treatment Market Forecast, By Distribution Channels 15.19.1. Hospital pharmacies 15.19.2. Retail pharmacies 15.19.3. Drug stores 15.20. Colombia Paget Disease Treatment Market Forecast, By Route Of Administration 15.20.1. Oral 15.20.2. Intravenous 15.20.3. Topical 15.21. Rest of South America Paget Disease Treatment Market Forecast, By Drug-Class 15.21.1. Bisphosphonates 15.21.2. Calcitonin analogues 15.21.3. Calcium supplements 15.21.4. Vitamin-D supplements 15.21.5. Analgesics 15.22. Rest of South America Paget Disease Treatment Market Forecast, By Distribution Channels 15.22.1. Hospital pharmacies 15.22.2. Retail pharmacies 15.22.3. Drug stores 15.23. Rest of South America Paget Disease Treatment Market Forecast, By Route Of Administration 15.23.1. Oral 15.23.2. Intravenous 15.23.3. Topical 15.24. South America Paget Disease Treatment Market Attractiveness Analysis 15.24.1. By Drug-Class 15.24.2. By Distribution Channels 15.24.3. By Route Of Administration 15.25. PEST Analysis 15.26. Key Trends 15.27. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Novartis AG 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Teva Pharmaceutical Industries Ltd. 16.3.3. Mylan NV 16.3.4. Neopharma Inc. 16.3.5. Allergan 16.3.6. Sanofi S.A. 16.3.7. Fresenius Kabi 16.3.8. Mallinckrodt Pharmaceuticals 16.3.9. Sun Pharmaceutical Industries Ltd. 17. Primary key Insights